BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12734205)

  • 1. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
    Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
    J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.
    Nelson VL; Legro RS; Strauss JF; McAllister JM
    Mol Endocrinol; 1999 Jun; 13(6):946-57. PubMed ID: 10379893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.
    Wickenheisser JK; Nelson-DeGrave VL; Hendricks KL; Legro RS; Strauss JF; McAllister JM
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4858-65. PubMed ID: 15914525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.
    Wood JR; Ho CK; Nelson-Degrave VL; McAllister JM; Strauss JF
    J Reprod Immunol; 2004 Aug; 63(1):51-60. PubMed ID: 15284005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
    Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
    Strauss JF
    Ann N Y Acad Sci; 2003 Nov; 997():42-8. PubMed ID: 14644808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
    McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
    Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells.
    Ho CK; Wood JR; Stewart DR; Ewens K; Ankener W; Wickenheisser J; Nelson-Degrave V; Zhang Z; Legro RS; Dunaif A; McAllister JM; Spielman R; Strauss JF
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6596-602. PubMed ID: 16159937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome.
    Wickenheisser JK; Biegler JM; Nelson-Degrave VL; Legro RS; Strauss JF; McAllister JM
    PLoS One; 2012; 7(11):e48963. PubMed ID: 23155436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.
    Wickenheisser JK; Nelson-DeGrave VL; Quinn PG; McAllister JM
    Mol Endocrinol; 2004 Mar; 18(3):588-605. PubMed ID: 14684846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
    Nelson-Degrave VL; Wickenheisser JK; Hendricks KL; Asano T; Fujishiro M; Legro RS; Kimball SR; Strauss JF; McAllister JM
    Mol Endocrinol; 2005 Feb; 19(2):379-90. PubMed ID: 15514033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate potentiates androgen biosynthesis in human ovarian theca cells.
    Nelson-DeGrave VL; Wickenheisser JK; Cockrell JE; Wood JR; Legro RS; Strauss JF; McAllister JM
    Endocrinology; 2004 Feb; 145(2):799-808. PubMed ID: 14576182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters.
    Daneshmand S; Weitsman SR; Navab A; Jakimiuk AJ; Magoffin DA
    Fertil Steril; 2002 Feb; 77(2):274-80. PubMed ID: 11821083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
    Wickenheisser JK; Nelson-Degrave VL; McAllister JM
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1720-7. PubMed ID: 15598676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to elucidate the mechanism of excessive theca cell androgen production in PCOS.
    Strauss JF; Wood JR; Christenson LK; McAllister JM
    Mol Cell Endocrinol; 2002 Jan; 186(2):183-8. PubMed ID: 11900894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome.
    Hogg K; Young JM; Oliver EM; Souza CJ; McNeilly AS; Duncan WC
    Endocrinology; 2012 Jan; 153(1):450-61. PubMed ID: 22087026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
    McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
    Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ovarian theca cells in culture.
    Wickenheisser JK; Nelson-DeGrave VL; McAllister JM
    Trends Endocrinol Metab; 2006 Mar; 17(2):65-71. PubMed ID: 16460956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.
    Wood JR; Nelson-Degrave VL; Jansen E; McAllister JM; Mosselman S; Strauss JF
    Physiol Genomics; 2005 Feb; 20(3):233-43. PubMed ID: 15598877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2.
    Tee MK; Speek M; Legeza B; Modi B; Teves ME; McAllister JM; Strauss JF; Miller WL
    Mol Cell Endocrinol; 2016 Oct; 434():25-35. PubMed ID: 27297658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.